POGO’s third reply to letters from Dr. Schatzberg and Dr. Nemeroff
POGO
by Scott H. Amey
December 16, 2010In response to your third letter, and after additional reviews of the numerous documents in our possession, the Project On Government Oversight will not be altering its November 29, 2010, revised letter to National Institutes of Health or blog entry, or issuing an apology. After a review of the February 25, 1997, “PRELIMINARY DRAFT” and of the 1999 published version of the handbook, POGO feels strongly that its statements regarding Scientific Therapeutics Information, Inc.’s development of the physician handbook titled Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care are accurate and supported by the evidence…
If you have any records showing that Dr. Nemeroff or Dr. Schatzberg authored “PRELIMINARY DRAFT” or that the timeline was amended to prohibit GSK’s involvement in the handbook, I’d be pleased to consider them and take any subsequent measures that POGO deems appropriate.
Finally, your recent letters appear to be on the behest of GSK’s due to your concerns about GSK’s involvement in the publication of the handbook. Due to potential conflicts of interest involving the publication of the handbook that exist between your clients, GSK, and STI, any future correspondence from POGO to you will cease until I receive a signed affidavit from you stating that you are not representing GSK or STI.
Sorry, the comment form is closed at this time.